We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Poisonous Shrub Offers Natural Pain Relief

By LabMedica International staff writers
Posted on 21 Jul 2011
An extract of the poisonous shrub Jatropha curcas acts as a strong painkiller and may have a manner of action different from conventional analgesics, such as morphine and other pharmaceutical agents. More...


The study’s findings were reported in the Volume 6, Number 2, 2011, issue of the International Journal of Biomedical Engineering and Technology. Drs. Omeh Yusuf and Ezeja Maxwell of the Micheal Okpara University of Agriculture (Umudike, Nigeria) explained how J. curcas, also known as the “physic nut,” is a perennial shrub that grows to 5 meters in height and belongs to the Euphobiaceace family. It is native to Central America but grows widely in other tropical and subtropical countries of Africa and Asia.

The plant’s fruit is combined with the stem bark of Cochlospermum planchonii in Nigerian medicine for treating diabetes mellitus and is also used traditionally as a painkiller. Other medicinal activities have been reported. The plant’s seeds have been used for making soap, candles, detergents, lubricants, and dyes and the seed oil is used in biodiesel.

The researchers extracted what they believed to be the physiologically active components of the leaves of J. curcas using methanol as solvent. They compared the effects of this extract at 100 mg/kg, 200 mg/kg, and 400 mg/kg of body mass, against 400 mg/kg of acetylsalicylic acid (aspirin) in standard laboratory animal tests for assessing the strength of painkillers.

The researchers discovered that 100 mg/kg was an inadequate dose, however, 200 mg/kg and 400 mg/kg doses produced analgesia comparable to aspirin, validating the use of the plant for pain relief in traditional medicine. The scientists suspect that the extract may be acting through both peripheral and central pain processes. Dr. Yusuf and Maxwell are now conducting more research on isolating and characterizing the active ingredient in the extract and in determining the precise mode of action.

The search for novel analgesic drugs that have a different side-effect profile and lack the tolerance and addiction problems associated with morphine and other opiates is a significant avenue of research in drug discovery science. Very few leads from traditional and herbal medicine are effective in generating a new product, but it should be noted, according to the investigators, that aspirin and morphine themselves were both originally derived from natural sources.

Related Links:
Micheal Okpara University of Agriculture


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.